Mualliflar

  • Хусанбаев Х.Ш., Юсупов А.Ф.

##semicolon##

оптическая когерентная томография–ангиография, диабетическая ретино-патия, лазеркоагуляция, витрэктомия, периметрия

##submission.citations##

Aiello LP et al. Diabetic retinopathy. N Engl J Med. 1998; 339:141-9.

Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy. PubMed, 2023. DOI: 37713065

Fallico M., et al. «Intravitreal anti‐vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta‐analysis». Acta Ophthalmologica, 2021. DOI: 10.1111/aos.14681

Gross JG et al. DRCR Retina Network: Five-Year Outcomes with Aflibercept, Bevacizumab, or Ranibizumab. Ophthalmology. 2020.

Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study. PubMed, 2023. DOI: 36755887

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA, 2015. DOI: 10.1001/jama.2015.10744

Perioperative anti-VEGF agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis. PubMed Central, 2020. DOI: PMC7641141

Progression to Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy. JAMA Ophthalmology, 2024. DOI: 10.1001/jamaophthalmol.2024.1844

World Health Organization. Global data on visual impairments. Geneva, 2019.

Yang Y et al. Panretinal photocoagulation and visual field loss. Retina. 2020.